Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference

EMERYVILLE, Calif.: EMERYVILLE, Calif., Jan. 5, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present at the H.C. Wainwright Virtual BioConnect 2022 Conference being held January 10-13, 2022. The on demand presentation...

Click to view original post